Last Price$126.3(1.2%)
Market Cap$36.5B
LTM Market Cap
$43.6B
5Y avg
$37.9B
Medical - Diagnostics & Research industry
median
$325.4M
Stock quality & Intrinsic value
7/10
(0.2%) overvalued
Agilent Technologies, Inc. Market Cap
Annual
Quarterly
LTM
Crunching data... Almost there!
| Oct'05 | Oct'06 | Oct'07 | Oct'08 | Oct'09 | Oct'10 | Oct'11 | Oct'12 | Oct'13 | Oct'14 | Oct'15 | Oct'16 | Oct'17 | Oct'18 | Oct'19 | Oct'20 | Oct'21 | Oct'22 | Oct'23 | Oct'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $9,881.0M | $9,545.1M | $9,512.4M | $5,654.6M | $6,156.1M | $8,636.8M | $10.2B | $8,943.6M | $12.1B | $13.0B | $12.5B | $14.0B | $21.7B | $20.3B | $23.5B | $31.4B | $47.7B | $41.1B | $29.5B | $38.1B |
Overvalued or undervalued?
Check the intrinsic value for A
and see if it's the right time to invest.
Agilent Technologies, Inc. (A) Market Cap comparison analysis
General
LTM Market Cap
OTHER METRICS
Company name
Revenue growth
EPS growth
Net Income margin
Agilent Technologies, Inc.A
$36.5B
(4.7%)
5.0%
19.8%
Median Peer Set
$24.6B
(0.3%)
(7.2%)
11.6%
Thermo Fisher Scientific Inc.TMO
$201.0B
(4.6%)
(12.4%)
14.0%
Danaher CorporationDHR
$151.3B
(0.1%)
(17.9%)
16.3%
IDEXX Laboratories, Inc.IDXX
$36.1B
8.7%
25.2%
23.1%
IQVIA Holdings Inc.IQV
$33.7B
2.8%
2.4%
8.9%
Mettler-Toledo International Inc.MTD
$27.1B
2.2%
12.7%
22.3%
Waters CorporationWAT
$22.2B
(0.5%)
(7.9%)
21.7%
Laboratory Corporation of America HoldingsLH
$21.2B
(18.3%)
(65.8%)
3.4%
Quest Diagnostics IncorporatedDGX
$19.6B
(6.4%)
(6.5%)
9.2%
Natera, Inc.NTRA
$18.5B
32.0%
(32.1%)
(40.2%)
Illumina, Inc.ILMN
$13.9B
(2.9%)
4.6%
(28.0%)
A key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Oct'05 | Oct'06 | Oct'07 | Oct'08 | Oct'09 | Oct'10 | Oct'11 | Oct'12 | Oct'13 | Oct'14 | Oct'15 | Oct'16 | Oct'17 | Oct'18 | Oct'19 | Oct'20 | Oct'21 | Oct'22 | Oct'23 | Oct'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 5,139.0 (28.4%) | 4,973.0 (3.2%) | 5,420.0 9.0% | 5,774.0 6.5% | 4,481.0 (22.4%) | 5,444.0 21.5% | 6,615.0 21.5% | 6,858.0 3.7% | 6,782.0 (1.1%) | 6,981.0 2.9% | 4,038.0 (42.2%) | 4,202.0 4.1% | 4,472.0 6.4% | 4,914.0 9.9% | 5,163.0 5.1% | 5,339.0 3.4% | 6,319.0 18.4% | 6,848.0 8.4% | 6,833.0 (0.2%) | 6,510.0 (4.7%) |
| Cost of Goods Sold (COGS) | 2,617.0 | 2,315.0 | 2,451.0 | 2,578.0 | 2,189.0 | 2,514.0 | 3,086.0 | 3,254.0 | 3,247.0 | 3,388.0 | 1,997.0 | 2,005.0 | 2,063.0 | 2,227.0 | 2,358.0 | 2,502.0 | 2,912.0 | 3,126.0 | 3,368.0 | 2,975.0 |
% margin | 2,522.0 49.1% | 2,658.0 53.4% | 2,969.0 54.8% | 3,196.0 55.4% | 2,292.0 51.1% | 2,930.0 53.8% | 3,529.0 53.3% | 3,604.0 52.6% | 3,535.0 52.1% | 3,593.0 51.5% | 2,041.0 50.5% | 2,197.0 52.3% | 2,409.0 53.9% | 2,687.0 54.7% | 2,805.0 54.3% | 2,837.0 53.1% | 3,407.0 53.9% | 3,722.0 54.4% | 3,465.0 50.7% | 3,535.0 54.3% |
| Operating Expenses | 2,341.0 | 2,194.0 | 2,385.0 | 2,401.0 | 2,245.0 | 2,364.0 | 2,458.0 | 2,485.0 | 2,584.0 | 2,762.0 | 1,519.0 | 1,582.0 | 1,568.0 | 1,759.0 | 1,864.0 | 1,991.0 | 2,060.0 | 2,104.0 | 2,115.0 | 2,047.0 |
| Research & Development Expenses (R&D) | 738.0 | 655.0 | 685.0 | 704.0 | 642.0 | 612.0 | 649.0 | 668.0 | 704.0 | 719.0 | 330.0 | 329.0 | 339.0 | 385.0 | 404.0 | 495.0 | 441.0 | 467.0 | 481.0 | 479.0 |
| Selling, General & Administrative Expenses (SG&A) | 1,603.0 | 1,660.0 | 1,700.0 | 1,697.0 | 1,603.0 | 1,752.0 | 1,809.0 | 1,817.0 | 1,880.0 | 2,043.0 | 1,189.0 | 1,253.0 | 1,229.0 | 1,374.0 | 1,460.0 | 1,496.0 | 1,619.0 | 1,637.0 | 1,634.0 | 1,568.0 |
% margin | 181.0 3.5% | 464.0 9.3% | 584.0 10.8% | 795.0 13.8% | 47.0 1.0% | 566.0 10.4% | 1,071.0 16.2% | 1,119.0 16.3% | 951.0 14.0% | 831.0 11.9% | 522.0 12.9% | 615.0 14.6% | 841.0 18.8% | 928.0 18.9% | 941.0 18.2% | 846.0 15.8% | 1,347.0 21.3% | 1,618.0 23.6% | 1,350.0 19.8% | 1,488.0 22.9% |
| Interest Income | 0.0 | 0.0 | 172.0 | 113.0 | 29.0 | 20.0 | 14.0 | 9.0 | 7.0 | 9.0 | 7.0 | 11.0 | 22.0 | 38.0 | 36.0 | 8.0 | 2.0 | 9.0 | 51.0 | 80.0 |
| Interest Expense | 0.0 | 0.0 | 91.0 | 123.0 | 88.0 | 96.0 | 86.0 | 101.0 | 107.0 | 113.0 | 66.0 | 72.0 | 79.0 | 75.0 | 74.0 | 78.0 | 81.0 | 84.0 | 95.0 | 96.0 |
| Pre-tax Income | 254.0 | 627.0 | 670.0 | 815.0 | 7.0 | 692.0 | 1,032.0 | 1,043.0 | 859.0 | 646.0 | 480.0 | 544.0 | 803.0 | 946.0 | 919.0 | 842.0 | 1,360.0 | 1,504.0 | 1,339.0 | 1,521.0 |
% effective tax rate | 155.0 61.0% | 91.0 14.5% | 32.0 4.8% | 122.0 15.0% | 38.0 542.9% | 68.0 9.8% | 20.0 1.9% | (110.0) (10.5%) | 135.0 15.7% | 149.0 23.1% | 45.0 9.4% | 84.0 15.4% | 119.0 14.8% | 630.0 66.6% | (152.0) (16.5%) | 123.0 14.6% | 150.0 11.0% | 250.0 16.6% | 99.0 7.4% | 232.0 15.3% |
% margin | 327.0 6.4% | 3,307.0 66.5% | 638.0 11.8% | 693.0 12.0% | (31.0) (0.7%) | 624.0 11.5% | 1,012.0 15.3% | 1,153.0 16.8% | 724.0 10.7% | 497.0 7.1% | 398.0 9.9% | 460.0 10.9% | 684.0 15.3% | 316.0 6.4% | 1,071.0 20.7% | 719.0 13.5% | 1,210.0 19.1% | 1,254.0 18.3% | 1,240.0 18.1% | 1,289.0 19.8% |
| EPS | 0.66 | 7.67 | 1.62 | 1.91 | (0.09) | 1.80 | 2.92 | 3.31 | 2.12 | 1.49 | 1.20 | 1.41 | 2.12 | 0.98 | 3.41 | 2.33 | 3.98 | 4.19 | 4.22 | 4.43 |
| Diluted EPS | 0.65 | 7.50 | 1.57 | 1.87 | (0.09) | 1.77 | 2.85 | 3.27 | 2.10 | 1.47 | 1.19 | 1.40 | 2.10 | 0.97 | 3.37 | 2.30 | 3.94 | 4.18 | 4.19 | 4.43 |
% margin | 396.0 7.7% | 634.0 12.7% | 775.0 14.3% | 1,139.0 19.7% | 257.0 5.7% | 788.0 14.5% | 1,395.0 21.1% | 1,445.0 21.1% | 758.0 11.2% | 648.0 9.3% | 778.0 19.3% | 863.0 20.5% | 1,096.0 24.5% | 1,181.0 24.0% | 1,281.0 24.8% | 1,353.0 25.3% | 1,725.0 27.3% | 1,994.0 29.1% | 1,703.0 24.9% | 1,488.0 22.9% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Agilent Technologies, Inc.'s Market Cap?
As of today, Agilent Technologies, Inc.'s last 12-month Market Cap is $43.6B, based on the financial report for Jan 30, 2025 (Q1’2025).
2) What is Agilent Technologies, Inc.'s Market Cap growth rate?
Over the last year, Agilent Technologies, Inc.'s Market Cap growth was 10.7%. The average annual Market Cap growth rates for Agilent Technologies, Inc. have been (2.1%) over the past three years, 10.7% over the past five years.
3) Is Agilent Technologies, Inc.'s Market Cap growth rate Good?
Over the last year, Agilent Technologies, Inc.'s Market Cap growth was 10.7%, which is higher than industry growth of 0.0%. It indicates that Agilent Technologies, Inc.'s Market Cap growth is Good.